Literature DB >> 6056632

The biosynthesis of 5-hydroxytryptamine in brain.

D G Grahame-Smith.   

Abstract

1. Studies on the anatomical distribution of tryptophan 5-hydroxylase in dog brain show that the activity of this enzyme parallels the activity of 5-hydroxytryptophan decarboxylase and the concentration of 5-hydroxytryptamine in various areas of the brain. 2. Subcellular fractionation of homogenates of rabbit hind-brain has shown that at least 40% of the tryptophan 5-hydroxylase activity is associated with the crude mitochondrial fraction; equilibrium centrifugation in a discontinuous sucrose gradient suggests that this particulate tryptophan 5-hydroxylase is localized in the synaptosomes (nerve-ending particles). 3. Attempts to increase the activity of tryptophan 5-hydroxylase in iso-osmotic homogenates of brain by adding 5,6,7,8-tetrahydro-6,7-dimethylpteridine failed. 4. Procedures designed to rupture synaptosomes caused a fall in the activity of tryptophan 5-hydroxylase, which fall was reversed by adding 5,6,7,8-tetrahydro-6,7-dimethylpteridine. This suggested either that the intact synaptosome, in which the tryptophan 5-hydroxylase is localized, contained an optimum amount of the pteridine, or that the pteridine could not pass across the nerve-cell membrane. 5. Partial purification of tryptophan 5-hydroxylase from brain preparations by ammonium sulphate precipitation revealed that the enzyme was completely dependent on 5,6,7,8-tetrahydro-6,7-dimethylpteridine for activity.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6056632      PMCID: PMC1198307          DOI: 10.1042/bj1050351

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  31 in total

1.  TYROSINE HYDROXYLASE. THE INITIAL STEP IN NOREPINEPHRINE BIOSYNTHESIS.

Authors:  T NAGATSU; M LEVITT; S UDENFRIEND
Journal:  J Biol Chem       Date:  1964-09       Impact factor: 5.157

2.  LACTATE DEHYDROGENASE AS A CYTOPLASMIC MARKER IN BRAIN.

Authors:  M K JOHNSON; V P WHITTAKER
Journal:  Biochem J       Date:  1963-09       Impact factor: 3.857

3.  SUBCELLULAR LOCALIZATION OF CATECHOLAMINES IN TISSUES OF THE RAT.

Authors:  L T POTTER; J AXELROD
Journal:  J Pharmacol Exp Ther       Date:  1963-12       Impact factor: 4.030

4.  EVIDENCE FOR THE EXISTENCE OF MONOAMINE NEURONS IN THE CENTRAL NERVOUS SYSTEM. IV. DISTRIBUTION OF MONOAMINE NERVE TERMINALS IN THE CENTRAL NERVOUS SYSTEM.

Authors:  K FUXE
Journal:  Acta Physiol Scand Suppl       Date:  1965

5.  The subcellular localization of 5-hydroxytryptamine in guinea pig brain.

Authors:  I A MICHAELSON; V P WHITTAKER
Journal:  Biochem Pharmacol       Date:  1963-02       Impact factor: 5.858

6.  The enzymic oxidation of tryptophan to 5-hydroxytryptophan in the biosynthesis of serotonin.

Authors:  J R COOPER; I MELCER
Journal:  J Pharmacol Exp Ther       Date:  1961-06       Impact factor: 4.030

7.  Paper chromatography of urinary indoles.

Authors:  J B JEPSON
Journal:  Lancet       Date:  1955-11-12       Impact factor: 79.321

8.  Intracellular distribution of choline acetylase.

Authors:  C O HEBB; B N SMALLMAN
Journal:  J Physiol       Date:  1956-11-28       Impact factor: 5.182

9.  5-Hydroxytryptophan decarboxylase: preparation and properties.

Authors:  C T CLARK; H WEISSBACH; S UDENFRIEND
Journal:  J Biol Chem       Date:  1954-09       Impact factor: 5.157

10.  Hydroxylation of tryptophan by phenylalanine hydroxylase.

Authors:  J RENSON; H WEISSBACH; S UDENFRIEND
Journal:  J Biol Chem       Date:  1962-07       Impact factor: 5.157

View more
  14 in total

1.  David Grahame Grahame-Smith: clinical pharmacologist. 1933-2011.

Authors:  Jeffrey K Aronson
Journal:  Br J Clin Pharmacol       Date:  2012-05       Impact factor: 4.335

2.  Tryptophan 5-hydroxylase in rat intestine.

Authors:  T Noguchi; M Nishino; R Kido
Journal:  Biochem J       Date:  1973-02       Impact factor: 3.857

3.  Effect of chronically administered L-dopa on dopa 5HTP decarboxylase and tyrosine and tryptophan hydroxylases in cat brain.

Authors:  A G Roberge; L J Poirier
Journal:  J Neural Transm       Date:  1973       Impact factor: 3.575

4.  Effects of carbamazepine on 5-hydroxytryptamine function in rodents.

Authors:  M Elphick; S M Anderson; K F Hallis; D G Grahame-Smith
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

5.  Inhibitory effect of chlorpromazine on the syndrome of hyperactivity produced by L-tryptophan or 5-methoxy-N,N-dimethyltryptamine in rats treated with a monoamine oxidase inhibitor.

Authors:  D G Grahame-Smith
Journal:  Br J Pharmacol       Date:  1971-12       Impact factor: 8.739

6.  Postanoxic myoclonus. Treatment of a case with 5-hydroxytryptophane and a decarboxylase inhibitor.

Authors:  E Beretta; F Regli; G de Crousaz; A J Steck
Journal:  J Neurol       Date:  1981       Impact factor: 4.849

Review 7.  Gaddum and LSD: the birth and growth of experimental and clinical neuropharmacology research on 5-HT in the UK.

Authors:  A R Green
Journal:  Br J Pharmacol       Date:  2008-05-26       Impact factor: 8.739

8.  Relationships between dietary ascorbic acid status and deficiency, weight gain and brain neurotransmitter levels in juvenile rainbow trout,Salmo gairdneri.

Authors:  W L Johnston; E Macdonald; J W Hilton
Journal:  Fish Physiol Biochem       Date:  1989-11       Impact factor: 2.794

9.  Changes with darkness in regional brain 5-hydroxytryptamine and 5-hydroxyindole acetic acid: local differences with pinealectomy, sham surgery, and melatonin.

Authors:  W B Quay
Journal:  Neurochem Res       Date:  1989-10       Impact factor: 3.996

10.  Serotonin receptor 2C and insulin secretion.

Authors:  Qiang Zhang; Yunxia Zhu; Wenbo Zhou; Lu Gao; Li Yuan; Xiao Han
Journal:  PLoS One       Date:  2013-01-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.